Skip to content

KMTS KMTS Non Cash Lease Expense

Non Cash Lease Expense at other companies

Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
$980K+14.4%
LBR
LB Pharmaceuticals Inc Common StockLBRX
$50K-62.4%
QuinStreet logo
QuinStreetQNST
$128K+12.3%
MapLight Therapeutics, Inc.
 logo
MapLight Therapeutics, Inc. MPLT
$229K+8.0%
HRO
HarrowHROW
$192K-11.5%
Kohl's logo
Kohl'sKSS
$22M+4.8%

Other financials

Income statement

See full
Revenue$24.6M+62.7%
Gross profit$12.9M+97.1%
Operating income-$34.8M-68.8%
Net income-$34.2M-58.8%
EPS (diluted)-$0.61+51.2%

Balance sheet

See full
Cash & equivalents$291.3M+436%
Total debt$43.8M
Total assets$379.3M

Cash flow

See full
Operating cash flow-$18.4M-2.1%
CapEx$9.8M+141%
Free cash flow-$28.2M-27.7%

Valuation

See full
Market cap$1.29B+67.0%
Enterprise value$1.04B
P/S15.4×

Profitability

See full
Gross margin48.8%+15.1pp
Operating margin-171.5%+12.9pp
Net margin-173%+0.8pp
FCF margin-142.9%-25.3pp

Returns & leverage

See full
Current ratio7.3×

Where this comes from

Reported directly by KMTS in its filing.

Tagged under the XBRL concept ck0001877184:NonCashLeaseExpense.

The official record: KMTS’s 10-Q, filed March 17, 2026, on SEC EDGAR. View the filing →

Ask your AI about KMTS's non cash lease expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is KMTS's non cash lease expense?
KMTS (KMTS) reported non cash lease expense of $125K in Q4 2025.
How has KMTS's non cash lease expense changed year-over-year?
KMTS's non cash lease expense increased by 42.0% year-over-year, from $88K to $125K.
What does non cash lease expense mean?
This represents the portion of lease expenses that does not involve an immediate cash outflow, typically related to the amortization of right-of-use assets. It is added back to net income in the cash flow statement to isolate the actual cash impact of lease obligations.